Angiotensin Converting Enzyme Inhibitors – Perindopril

Generic Name

perindopril                     

Strength 2 mg, 4 mg, 8 mg

Form

tablet

Criteria

Approval Period

  1. Treatment failure on optimal dose of, or intolerance to, ramipril. 

OR

  1. Complex patient requiring medications for co-existing chronic condition(s).

Indefinite

Practitioner Exemptions

Practitioners in the following specialty are not required to submit a Special Authority request form for coverage:

  • Paediatric Cardiology
  • Paediatrics

Special Notes

  • PharmaCare does not cover perindopril in combination with indapamide.
  • Patients with co-existing chronic conditions requiring use of multiple medications will be considered complex for the purposes of Special Authority criteria.

Special Authority Request Form(s)